Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

MSN Laboratories Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (29)

Date

2026 (6)
2025 (8)
2024 (2)
2022 (8)
2021 (4)
2019 (1)

Search

Sponsor content

29 result(s) found, displaying 21 to 29

SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule bottle (370767)

22 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 50 mg hard capsule bottle.
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule blister pack (370764)

22 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule blister pack.
SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle (370766)

22 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 25 mg hard capsule bottle.
SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule bottle (370765)

22 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SUNITINIB MSN sunitinib (as malate) 12.5 mg hard capsule bottle.
MSN DASATINIB dasatinib 70 mg film-coated tablet blister pack (335108)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN DASATINIB dasatinib 70 mg film-coated tablet blister pack.
MSN DASATINIB dasatinib100 mg film-coated tablet blister pack (335105)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN DASATINIB dasatinib100 mg film-coated tablet blister pack.
MSN DASATINIB dasatinib 50 mg film-coated tablet blister pack (335103)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN DASATINIB dasatinib 50 mg film-coated tablet blister pack.
MSN DASATINIB dasatinib 20 mg film-coated tablet blister pack (335104)

25 March 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN DASATINIB dasatinib 20 mg film-coated tablet blister pack.
MSN-BORTEZOMIB bortezomib 3.5 mg powder for injection vial (306550)

14 May 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-BORTEZOMIB bortezomib 3.5 mg powder for injection vial.

Pages

First page
Previous page
Page 1
Page 2
Current page 3

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.